[HTML][HTML] Superior mesenteric artery (SMA) resection during pancreatectomy for malignant disease of the pancreas: a systematic review

S Jegatheeswaran, M Baltatzis, S Jamdar… - HPB, 2017 - Elsevier
Background Resection of the superior mesenteric artery (SMA) during pancreatectomy is
performed infrequently and is undertaken with the aim of removing non-metastatic locally …

[HTML][HTML] Oncovascular surgery: essential roles of vascular surgeons in cancer surgery

A Han, S Ahn, SK Min - Vascular Specialist International, 2019 - ncbi.nlm.nih.gov
For the modern practice of cancer surgery, the concept of oncovascular surgery (OVS),
defined as cancer resection with concurrent ligation or reconstruction of a major vascular …

A phase 1 study of stereotactic body radiation therapy dose escalation for borderline resectable pancreatic cancer after modified FOLFIRINOX (NCT01446458)

WL Shaib, N Hawk, RJ Cassidy, Z Chen… - International Journal of …, 2016 - Elsevier
Purpose A challenge in borderline resectable pancreatic cancer (BRPC) management is the
high rate of positive posterior margins (PM). Stereotactic body radiation therapy (SBRT) …

Radical Resection for Locally Advanced Pancreatic Cancers in the Era of New Neoadjuvant Therapy—Arterial Resection, Arterial Divestment and Total …

Y Inoue, A Oba, Y Ono, T Sato, H Ito, Y Takahashi - Cancers, 2021 - mdpi.com
Simple Summary Aggressive arterial resection or total pancreatectomy in surgical treatment
for locally advanced pancreatic cancer (LAPC) has gradually been encouraged thanks to …

[HTML][HTML] Technical aspects of pancreaticoduodenectomy and their outcomes

K Giuliano, A Ejaz, J He - Chinese clinical oncology, 2018 - cco.amegroups.org
Pancreatic cancer is the fourth leading cause of cancer-related death in the Unites States
and is rising in incidence. For the 15–25% of patients who do not have either metastatic or …

The value of combined vein resection in pancreaticoduodenectomy for pancreatic head carcinoma: a meta-analysis

C Peng, D Zhou, L Meng, Y Cao, H Zhang, Z Pan, C Lin - BMC surgery, 2019 - Springer
Background Although pancreaticoduodenectomy with vein resection (PDVR) is widely
performed in selected patients with indications, its benefits remain controversial. In this meta …

[HTML][HTML] The effect of centralization on short term outcomes of pancreatoduodenectomy in a universal health care system

LS Nymo, K Søreide, D Kleive, F Olsen, K Lassen - HPB, 2019 - Elsevier
Background Centralization of pancreatic resections is advocated due to a volume-outcome
association. Pancreatic surgery is in Norway currently performed only in five teaching …

Towards an updated view on the clinical management of pancreatic adenocarcinoma: Current and future perspectives

L Pekarek, O Fraile-Martinez… - Oncology …, 2021 - spandidos-publications.com
Pancreatic cancer has a dire prognosis and will represent the second leading cause of
cancer death in the next 10 years. The multifactorial approach represents one of the main …

The impact of venous resection in pancreatoduodectomy: A systematic review and meta-analysis

JEL Pinheiro Filho, F Tustumi, FF Coelho, SS Júnior… - Medicine, 2021 - journals.lww.com
Background: Vein resection pancreatoduodenectomy (VRPD) may be performed in selected
pancreatic cancer patients. However, the main risks and benefits related to VRPD remain …

An improved staging system for locally advanced pancreatic cancer: a critical need in the multidisciplinary era

MW Fromer, J Hawthorne, P Philips, ME Egger… - Annals of Surgical …, 2021 - Springer
Background Locally-advanced pancreatic cancer (LAPC) is traditionally considered stage III
unresectable disease. Advances in induction systemic therapy regimens, surgical technique …